Summary of CDR3 size spectratyping results from 19 BMT recipients.

CDR3 size profiles were determined in PBMCs sampled at several time points after BMT for each patient. All patients underwent DLIs as indicated ↓. GvHD developed in 4 patients after DLI. ○ indicates that all spectratypes are abnormal; ✺ indicates that some spectratypes are normal; and • indicates that all spectratypes are normal. * indicates a patient in whom GVHD developed.